gene therapy

Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Fierce Pharma
Tue, 04/21/20 - 12:11 pm
Merck KGaA
MilliporeSigma
gene therapy
drug manufacturing
Takeda and Evotec Enter into Gene Therapy Research Alliance
BioSpace
Mon, 04/6/20 - 09:43 pm
Takeda
Evotec
gene therapy
R&D
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy
Xconomy
Tue, 03/31/20 - 10:49 am
SMA
Novartis
gene therapy
Zolgensma
Novartis publishes long-term data from SMA gene therapy
Pharmaforum
Tue, 03/24/20 - 10:31 am
Novartis
Zolgensma
gene therapy
SMA
Big pharma shied away from gene therapy for years. Academia picked up the slack
BioPharma Dive
Tue, 03/17/20 - 11:31 pm
gene therapy
academic research
Novartis sidesteps Europe travel ban to provide CAR-T drug Kymriah to patients
Fierce Pharma
Fri, 03/13/20 - 12:41 pm
Novartis
Europe
Donald Trump
gene therapy
Kymriah
COVID-19
In its first use inside the human body, CRISPR genome editing tested as blindness therapy
Stat
Wed, 03/4/20 - 10:50 am
gene therapy
blindness
CRISPR
genome editing
Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital
Endpoints
Tue, 03/3/20 - 11:58 pm
Akouos
hearing loss
gene therapy
Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO
Endpoints
Fri, 02/28/20 - 10:37 am
Passage Bio
IPOs
gene therapy
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
BioMarin's Novel Treatment Promises to Disrupt Competitors
Motley Fool
Wed, 02/26/20 - 10:45 am
Biomarin
gene therapy
valrox
hemophilia A
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Fri, 02/21/20 - 11:39 pm
Repligen
earnings
gene therapy
FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review
Motley Fool
Thu, 02/20/20 - 11:41 pm
FDA
Biomarin
priority review
valrox
gene therapy
hemophilia A
FDA Awards Orphan Drug Designation to Prevail's Gene Therapy for Gaucher Disease
BioSpace
Fri, 02/14/20 - 10:47 am
FDA
Prevail Therapeutics
gene therapy
Gaucher disease
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Novartis faces criticism over Zolgensma ‘health lottery’
PM Live
Thu, 02/6/20 - 11:51 pm
Novartis
SMA
gene therapy
Zolgensma
lottery
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
Forbes
Thu, 02/6/20 - 11:37 pm
Biomarin
valrox
gene therapy
hemophilia A
Catalent laying out $315M to snatch another gene therapy CDMO
Fierce Pharma
Mon, 02/3/20 - 10:39 am
Catalent
gene therapy
Paragon Services
CDMOs
FDA Expects Explosion in Gene Therapy Treatments, Updates Review Policy
Motley Fool
Tue, 01/28/20 - 11:43 pm
FDA
gene therapy
Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub
Endpoints
Sat, 01/25/20 - 11:27 pm
Deerfield Management
gene therapy
IPOs
CDMOs
Philadelphia

Pages